CART-EGFR-IL13Ra2

· University of Pennsylvania

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CART-EGFR-IL13Ra2, covering 2025-07-24 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM [Phase 1]